The Patent Finder

Probiodrug AG

Also on record
Records under this name other than the patents Probiodrug AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.

Back to Probiodrug AG

PatentTitleStatus Expires Confidence
US 8,889,709Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,676,843Uses of antibodies directed against amyloid-β
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,058,405Antibodies specific for N-terminal truncated and pyroglutamate modified amyloid-beta peptides
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,173,885Inhibitors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,650,362Inhibitors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,486,940Inhibitors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,269,019Inhibitors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,420,828Inhibitors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,541,596Inhibitors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,962,860Novel Inhibitors of Glutaminyl Cyclase
Formerly held
In force
 · Medium confidence
In forceMedium confidence
10 of 77 patents shown.
Pro members see all 77.
Pro members: see all 77 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited